Home > Insider Trading > Filing (0001439222-25-000011)

Filing Details

Accession Number:: 0001439222-25-000011
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2025-03-04 16:06:56
Reporting Period:: 2025-03-01

Filing Date:: 2025-03-04
Accepted Time:: 2025-03-04 16:06:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1439222	Agios Pharmaceuticals Inc.	AGIO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1874199	Jr. James Theodore Washburn	88 Sidney Street Cambridge MA 02139	Principal Accounting Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2025-03-01	777	$0.00	6,269	No	4	M	Direct
Common Stock	Disposition	2025-03-03	231	$35.54	6,038	No	4	S	Direct
Common Stock	Acquisiton	2025-03-01	2,350	$0.00	8,388	No	4	M	Direct
Common Stock	Disposition	2025-03-03	697	$35.54	7,691	No	4	S	Direct
Common Stock	Acquisiton	2025-03-01	2,450	$0.00	10,141	No	4	M	Direct
Common Stock	Disposition	2025-03-03	727	$35.54	9,414	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted stock units	Acquisiton	2025-03-01	8,085	$0.00	8,085	$0.00
Common Stock	Restricted stock units	Acquisiton	2025-03-01	6,142	$0.00	6,142	$0.00
Common Stock	Restricted stock units	Disposition	2025-03-01	777	$0.00	777	$0.00
Common Stock	Restricted stock units	Disposition	2025-03-01	2,350	$0.00	2,350	$0.00
Common Stock	Restricted stock units	Disposition	2025-03-03	2,450	$0.00	2,450	$0.00

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,085	No	4	A	Direct
6,142	No	4	A	Direct
0	No	4	M	Direct
2,350	No	4	M	Direct
4,900	No	4	M	Direct

Footnotes

Includes 55 shares purchased through the Company's employee stock purchase plan.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2022.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2023.
Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock units. This transaction was effected pursuant to durable automatic sale instructions consistent with the affirmative defense to liability under Section 10(b) of the Securities Exchange Act of 1934 under Rule 10b5-1(c) promulgated under such Act. Such instructions were included in the reporting person's restricted stock unit agreement dated March 1, 2024.
Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
The restricted stock units were granted on March 1, 2025. Beginning on March 1, 2026, the shares underlying the restricted stock units will vest in three equal annual installments.
The restricted stock units were granted on March 1, 2025. On February 1, 2027, the shares underlying the restricted stock units will vest in full.
The restricted stock units were granted on March 1, 2022. Beginning on March 1, 2023, the shares underlying the restricted stock units will vest in three equal annual installments.
The restricted stock units were granted on March 1, 2023. Beginning on March 1, 2024, the shares underlying the restricted stock units will vest in three equal annual installments.
The restricted stock units were granted on March 1, 2024. Beginning on March 1, 2025, the shares underlying the restricted stock units will vest in three equal annual installments.